Sharda Cropchem Limited has announced that its Board of Directors will meet on January 29, 2026, to review and approve the company's third-quarter financial performance for FY26. The meeting will focus on considering the unaudited financial results for both standalone and consolidated operations.

Board Meeting Agenda

The Board meeting has been scheduled to address several key corporate matters as outlined in the company's regulatory filing dated January 20, 2026.

Financial Results Review

The Board will consider, approve and take on record the unaudited financial results covering both standalone and consolidated operations for the quarter and nine months ended December 31, 2025. This review represents the company's third-quarter performance for the Financial Year 2025-26.

Dividend Consideration

As part of the meeting agenda, the Board will deliberate on declaring an interim dividend on the paid-up equity share capital of the company for Financial Year 2025-26. The final decision on dividend declaration will be made during the Board meeting.

Trading Window Closure

In compliance with SEBI regulations on insider trading prevention, Sharda Cropchem Limited has implemented a trading window closure for all designated employees and connected persons.

Regulatory Compliance

The announcement has been made in accordance with Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both the National Stock Exchange of India Limited and BSE Limited about the scheduled Board meeting and trading window closure.

The communication was signed by Jetkin Gudhka, Company Secretary and Compliance Officer, ensuring proper corporate governance and regulatory adherence in the disclosure process.

Sharda Cropchem , a prominent player in the agrochemical sector, has announced upward revisions to its financial projections for the fiscal year 2026 (FY26), indicating an improved business outlook and expectations of enhanced operational efficiency.

Margin Guidance Boost

The company has raised its FY26 margin guidance to a range of 18-20%, up from the previous projection of 15-18%. This upward adjustment suggests that Sharda Cropchem anticipates stronger profitability in the coming years.

Revenue Growth Forecast

In addition to the margin improvement, Sharda Cropchem has also increased its revenue growth forecast. The company now expects a 20% growth in revenue, a notable increase from the earlier projection of 15%.

Financial Projections Overview

To better illustrate the changes in Sharda Cropchem's financial projections, here's a comparison of the previous and revised guidance:

Implications for the Company

The upward revision in both margin and revenue growth forecasts is a positive indicator for Sharda Cropchem. These adjustments suggest that the company:

1. Anticipates improved operational efficiency
2. Expects stronger market demand for its products
3. May have implemented successful cost management strategies
4. Foresees a favorable business environment in the agrochemical sector

While these revised projections paint an optimistic picture for Sharda Cropchem's future performance, it's important to note that these are forward-looking statements. Actual results may vary based on various factors including market conditions, regulatory environment, and global economic trends affecting the agrochemical industry.

Investors and market analysts will likely keep a close watch on Sharda Cropchem's performance in the coming quarters to see if the company's actual results align with these upgraded projections.